You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DMAC Award Disclosure
Pauls Dietrich John · SEC Form 4 · Filed Aug 12, 2026
Award
Calculated transaction value
$0
Pauls Dietrich John President & CEO
DMAC
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
DMAC daily price context
Close on/before transaction
$6.65
Aug 10, 2026
First close after public filing
$6.75
Aug 13, 2026
30-day return after filing
-4.15%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Voting Common Shares, no par value per share
- Quantity / price
- 60,200 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001760123-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Diamedica Therapeutics Inc. DMAC Current | Award | Aug 10, 2026 | $0 |